Valuation Black Diamond Therapeutics, Inc.
Stocks
BDTX
US09203E1055
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
23:00:00 18/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.960 USD | +1.55% |
|
-1.01% | -19.34% |
Company Valuation: Black Diamond Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 193.1 | 65.46 | 145.1 | 121.1 | 138.4 | 112.6 | - | - |
| Change | - | -66.1% | 121.66% | -16.54% | 14.33% | -18.66% | - | - |
| Enterprise Value (EV) | -16.69 | -57.35 | 145.1 | 121.1 | 138.4 | 112.6 | 112.6 | 112.6 |
| Change | - | -243.68% | 353.01% | -16.54% | 14.33% | -18.66% | 0% | 0% |
| P/E | -1.54x | -0.71x | -1.49x | -1.69x | 6.23x | -3.18x | -2.06x | -2.12x |
| PBR | 0.98x | - | - | - | - | - | - | - |
| PEG | - | 0x | 0.1x | 0.1x | -0x | 0x | -0x | 0.75x |
| Capitalization / Revenue | - | - | - | - | 1.98x | 18x | - | - |
| EV / Revenue | - | - | - | - | 0x | 18x | - | - |
| EV / EBITDA | 0x | 0x | - | -0x | 0x | -2.32x | -1.69x | -1.38x |
| EV / EBIT | 0x | 0x | -0x | -0x | 0x | -2.61x | -1.63x | -1.23x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.47 | -2.52 | -1.88 | -1.27 | 0.39 | -0.6162 | -0.9525 | -0.9257 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 70 | 6.25 | - | - |
| EBITDA 1 | -126.7 | -92.32 | - | -78.44 | 20.2 | -48.52 | -66.52 | -81.66 |
| EBIT 1 | -126.9 | -92.83 | -86.46 | -78.78 | 19.87 | -43.14 | -69.02 | -91.83 |
| Net income 1 | -125.6 | -91.17 | -82.44 | -69.68 | 22.37 | -36.96 | -64.65 | -87.39 |
| Net Debt | -209.8 | -122.8 | - | - | - | - | - | - |
| Reference price 2 | 5.330 | 1.800 | 2.810 | 2.140 | 2.430 | 1.960 | 1.960 | 1.960 |
| Nbr of stocks (in thousands) | 36,229 | 36,366 | 51,635 | 56,585 | 56,975 | 57,454 | - | - |
| Announcement Date | 3/17/22 A | 3/9/23 A | 3/12/24 A | 3/6/25 A | 3/16/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.18x | - | - | - | 113M | |
| 20.78x | 7.37x | 14.79x | 1.43% | 70.88B | |
| 32.47x | 9.38x | 45.35x | 0.04% | 62.49B | |
| -73.25x | 14.16x | -68.28x | -.--% | 26.21B | |
| 30.44x | 6.47x | 16.8x | -.--% | 26.34B | |
| -14.7x | 5.35x | -6.73x | -.--% | 24.13B | |
| 28.25x | 5.33x | 17.72x | -.--% | 20.72B | |
| 44.51x | 16.33x | 33.12x | 0.34% | 15.36B | |
| 18.03x | 5.37x | 12.55x | -.--% | 14.46B | |
| -15.41x | 3483.86x | -17.81x | -.--% | 14.25B | |
| Average | 6.79x | 394.85x | 5.28x | 0.2% | 27.5B | |
| Weighted average by Cap. | 12.15x | 188.68x | 11.56x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BDTX Stock
- Valuation Black Diamond Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
